BAY-876 |
Inhibitor of SLC2A1
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| SLC2A1 |
|
|
Inhibitor
up to 100 nM
Selectivity
In Vitro Selectivity Assessment
Selectivity Assessment Description:
Selectivity within target family: the closest target is SLC2A4 which is >100x less selective (IC50 = ...
Potency Cellular
In Vitro
SLC2A1
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? No
DOI Reference: 10.1002/cmdc.201600276
In Vivo Validations
Rat
Dose: 0.3 mg/Kg
Route of delivery:
Intravenous
Plasma half life:
2.5 h
Systemic clearance:
0.23 (plasma), 0.33 (blood) L/h/Kg
Volume of Distribution at Steady-State:
0.79 L/Kg
DOI Reference: 10.1002/cmdc.201600276
Dose: 0.6 mg/Kg
Route of delivery:
Oral
Cmax:
0.33 Kg/L
Bioavailability:
85%
DOI Reference: 10.1002/cmdc.201600276
Dog
Dose: 0.1 mg/Kg
Route of delivery:
Intravenous
Plasma half life:
22 h
Systemic clearance:
0.033 (plasma), 0.059 (blood) L/h/Kg
Volume of Distribution at Steady-State:
1.0 L/Kg
DOI Reference: 10.1002/cmdc.201600276
Dose: 0.2 mg/Kg
Route of delivery:
Oral
Cmax:
0.93 Kg/L
Bioavailability:
79%
DOI Reference: 10.1002/cmdc.201600276
Negative Control Compounds
Chemical Information
| Molecular Formula | C24H16F4N6O2 |
| SMILEs | Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1 |
| InChI | InChI=1S/C24H16F4N6O2/c1-12-20(21(24(26,27)28)33-34(12)11-14-4-2-13(10-29)3-5-14)32-23(36)17-9-19(22(30)35)31-18-8-15(25)6-7-16(17)18/h2-9H,11H2,1H3,(H2,30,35)(H,32,36) |
| Molecular weight | 496.13 Da |
| AlogP | 4.168800000000002 |
| HBond acceptors | 8 |
| HBond donors | 3 |
| Atoms | 52 |
References
Publications
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.